VO-Ohpic (trihydrate)
VO-Ohpic trihydrate is a highly potent inhibitor of PTEN with an IC50 of 46±10 nM.
Product Specifications
CAS Number
[476310-60-8]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Autophagy; PTEN
Type
Reference compound
Related Pathways
Autophagy; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/VO-Ohpic-trihydrate.html
Purity
98.0
Solubility
DMSO : ≥ 50 mg/mL|H2O : < 0.1 mg/mL
Smiles
O=C1[O-][V+2]2([O-]C(C3=[N]2C=CC=C3O)=O)([O-]C4=CC=CN=C14)([OH2])=O.[H+].[3H2O]
Molecular Formula
C12H16N2O11V
Molecular Weight
415.20
Precautions
H302, H315, H319, H335
References & Citations
[1]Mak LH, et al. Characterisation of the PTEN inhibitor VO-OHpic.
 J Chem Biol. 2010 Oct;3 (4) :157-63.|[2]Rosivatz, E, et al. A small molecule inhibitor for phosphatase and tensin homologue deleted on chromosome 10 (PTEN) . ACS Chem Biol. 2006 Dec 15;1 (12) :780-90.|[3]Zu L, et al. PTEN inhibitors cause a negative inotropic and chronotropic effect in mice.
 Eur J Pharmacol. 2011 Jan 10;650 (1) :298-302.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Citation 01
Biochem Pharmacol. 2019 Oct:168:82-90.|Biochem Pharmacol. 2020 Jan;171:113715.|Biochim Biophys Acta Mol Basis Dis. 2022 Jan 1;1868 (1) :166292.|BMC Cancer. 2019 Apr 25;19 (1) :391.|Bone Res. 2018 Nov 10;6:32.|Cancer Med. 2019 Aug;8 (9) :4265-4277.|Cell Biol Toxicol. 2025 Feb 27;41 (1) :53.|Cell Death Dis. 2019 May; 10 (5) : 329.|Cell Stem Cell. 2022 Apr 7;29 (4) :545-558.e13.|Clin Transl Med. 2020 Dec;10 (8) :e240.|Clin Transl Med. 2022 Sep;12 (9) :e1061.|Environ Sci Technol. 2020 Sep 1;54 (17) :10783-10796.|Eur Rev Med Pharmacol Sci. 2019 May;23 (10) :4406-4413.|Funct Integr Genomics. 2024 Apr 3;24 (2) :71.|Int Immunopharmacol. 2022 Feb:103:107840.|Int J Mol Med. 2021 Jun;47 (6) :109.|Int J Mol Sci. 2023 Jun 9;24 (12) :9954.|iScience. 2024 Jun 19;27 (7) :110306.|J Adv Res. 2025 Aug:74:589-607.|J Cell Mol Med. 2019 Nov;23 (11) :7535-7544.|Mol Med Rep. 2018 Dec;18 (6) :5489-5501.|Mol Med Rep. 2022 Jul;26 (1) :246.|Mol Nutr Food Res. 2019 Dec;63 (24) :e1900418.|Mol Vis. 2018 Jul 23:24:485-494.|Redox Biol. 2019 Jan;20:390-401. |Redox Biol. 2024 May 17:73:103200.|Stem Cell Res Ther. 2019 Jul 29;10 (1) :217.|Theranostics. 2019 Jul 9;9 (16) :4764-4778.|Theranostics. 2019 Jul 9;9 (18) :5200-5213.|Transl Psychiatry. 2021 Mar 26;11 (1) :185.|Cell Death Dis. 2025 Aug 7;16 (1) :595.|J Nanobiotechnology. 2025 May 25;23 (1) :376.|Phytomedicine. 2023 Dec:121:155117.|SSRN. 2023 Jul 17.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
